Gilead Sciences
GILD
#97
Rank
โ‚ฌ157.61 B
Marketcap
127,04ย โ‚ฌ
Share price
-1.04%
Change (1 day)
21.55%
Change (1 year)

Gilead Sciences (GILD) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ49.63 Billion

According to Gilead Sciences's latest financial reports the company's total assets are โ‚ฌ49.63 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Gilead Sciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ56.69 B0.88%
2023-12-31โ‚ฌ56.19 B-4.57%
2022-12-31โ‚ฌ58.89 B-1.85%
2021-12-31โ‚ฌ60.00 B7.89%
2020-12-31โ‚ฌ55.61 B1.1%
2019-12-31โ‚ฌ55.01 B-1.16%
2018-12-31โ‚ฌ55.66 B-4.98%
2017-12-31โ‚ฌ58.57 B8.14%
2016-12-31โ‚ฌ54.16 B14.52%
2015-12-31โ‚ฌ47.29 B65.95%
2014-12-31โ‚ฌ28.50 B74.33%
2013-12-31โ‚ฌ16.34 B1.82%
2012-12-31โ‚ฌ16.05 B20.51%
2011-12-31โ‚ฌ13.32 B52.88%
2010-12-31โ‚ฌ8.71 B28.75%
2009-12-31โ‚ฌ6.76 B36.43%
2008-12-31โ‚ฌ4.96 B24.17%
2007-12-31โ‚ฌ3.99 B29.05%
2006-12-31โ‚ฌ3.09 B-2.6%
2005-12-31โ‚ฌ3.17 B100.04%
2004-12-31โ‚ฌ1.58 B28.7%
2003-12-31โ‚ฌ1.23 B0.21%
2002-12-31โ‚ฌ1.23 B36.93%
2001-12-31โ‚ฌ0.89 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ168.91 B 240.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ176.98 B 256.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ113.53 B 128.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ95.36 B 92.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ76.43 B 54.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ24.96 B-49.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ5.63 B-88.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ21.08 B-57.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ109.84 B 121.32%๐Ÿ‡บ๐Ÿ‡ธ USA